🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Andrés F. Cardona

ORCID: 0000-0003-3525-4126

Also affiliated with Université de Lille, Centre Hospitalier Universitaire de Lille, Addario Lung Cancer Medical Institute, Centre de Recherche en Cancérologie de Lyon, Foundation for Clinical and Applied Cancer Research, Onco Lille, CANTHER - Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer”.

Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

Journal of Experimental & Clinical Cancer Research(2022)10.1186/s13046-022-02379-1

N/A

0.710DataRank · unranked

113 citations

Alessandro Russo, Óscar Arrieta, Murat Ak, Feliciano Barrón, Muthukumar Gunasekaran +20 more

Extracellular vesicles containing SARS‐CoV‐2 proteins are associated with multi‐organ dysfunction and worse outcomes in patients with severe COVID‐19

Journal of Extracellular Vesicles(2024)10.1002/jev2.70001

N/A

0.373DataRank · unranked

11 citations

Marisol Arroyo‐Hernández, Sabrina La Salvia, Muthukumar Gunasekaran, Edward M. Pickering, Stephanie V. Avila +18 more

Immunotherapy Resistance in Non-Small Cell Lung Cancer: A Rubik's Cube to Assemble

Journal of Immunotherapy and Precision Oncology(2021)10.36401/jipo-21-7

N/A

0DataRank · unranked

3 citations

Camila Ordóñez‐Reyes, Andrés F. Cardona, Christian Rolfo

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial

Neuro-Oncology(2022)10.1093/neuonc/noac173

N/A

0DataRank · unranked

153 citations

Stephanie L. Pugh, Tony J. C. Wang, Kenneth Aldape, Hui Gan, Matthias Preusser +27 more